ReP USP - Resultado da busca

Artigo de periodico
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)
Dicker, Daniel; Nguyen, Grant; Abate, Degu; Abate, Kalkidan Hassen; Abay, Solomon M; Abbafati, Cristiana; Abbasi, Nooshin; Abbastabar, Hedayat; Abd-Allah, Foad; Abdela, Jemal; Furtado, João Marcello Fortes
Source: Lancet. Unidade: FMRP
Subjects: MORTALIDADE, EPIDEMIOLOGIA ANALÍTICA, CONDIÇÕES DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DICKER, Daniel et al. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, v. 392, n. 10159, p. 1684-1735, 2018Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(18)31891-9. Acesso em: 06 out. 2024.
APA
Dicker, D., Nguyen, G., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., et al. (2018). Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392( 10159), 1684-1735. doi:10.1016/s0140-6736(18)31891-9
NLM
Dicker D, Nguyen G, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Furtado JMF. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 [Internet]. Lancet. 2018 ; 392( 10159): 1684-1735.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/s0140-6736(18)31891-9
Vancouver
Dicker D, Nguyen G, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Furtado JMF. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 [Internet]. Lancet. 2018 ; 392( 10159): 1684-1735.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/s0140-6736(18)31891-9
Artigo de periodico
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Source: Lancet. Unidades: FM, FMRP
Subjects: PROMOÇÃO DA SAÚDE, ACORDOS INTERNACIONAIS, DESENVOLVIMENTO SUSTENTÁVEL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1423-1459, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32336-X. Acesso em: 06 out. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1423-1459. doi:10.1016/S0140-6736(17)32336-X
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1423-1459.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32336-X
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1423-1459.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32336-X
Artigo de periodico
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Goulart, Alessandra Carvalho; Furtado, João Marcello Fortes
Source: Lancet. Unidades: FM, HU, FMRP
Subjects: CONTROLE DE DOENÇAS NÃO TRANSMISSÍVEIS, MORTALIDADE, EPIDEMIOLOGIA ANALÍTICA, SAÚDE PÚBLICA, CONTROLE DE DOENÇAS TRANSMISSÍVEIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1211-1259, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32154-2. Acesso em: 06 out. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., Goulart, A. C., & Furtado, J. M. F. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1211-1259. doi:10.1016/S0140-6736(17)32154-2
NLM
Lotufo PA, Benseñor IJM, Goulart AC, Furtado JMF. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1211-1259.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32154-2
Vancouver
Lotufo PA, Benseñor IJM, Goulart AC, Furtado JMF. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1211-1259.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32154-2
Artigo de periodico
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Source: Lancet. Unidades: FM, FMRP
Subjects: FATORES SOCIOECONÔMICOS, MORTALIDADE, EPIDEMIOLOGIA ANALÍTICA, SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1260-1344, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32130-X. Acesso em: 06 out. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1260-1344. doi:10.1016/S0140-6736(17)32130-X
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1260-1344.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32130-X
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1260-1344.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32130-X
Artigo de periodico
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Source: Lancet. Unidades: FM, FMRP
Subjects: ANÁLISE GLOBAL, MORTALIDADE INFANTIL, FATORES DE RISCO, EXPECTATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article. Lancet, v. 390, n. 10100, p. 1084-1150, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)31833-0. Acesso em: 06 out. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article. Lancet, 390( 10100), 1084-1150. doi:10.1016/S0140-6736(17)31833-0
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article [Internet]. Lancet. 2017 ; 390( 10100): 1084-1150.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)31833-0
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article [Internet]. Lancet. 2017 ; 390( 10100): 1084-1150.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)31833-0
Artigo de periodico
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Goulart, Alessandra Carvalho; Santos, Itamar de Souza; Benseñor, Isabela M; Lotufo, Paulo Andrade; Furtado, João Marcello Fortes; Wang, Yuan-Pang
Source: Lancet. Unidades: FM, FMRP, HU
Subjects: MORTALIDADE, DOENÇAS TRANSMISSÍVEIS, CAUSA DA MORTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOULART, Alessandra Carvalho et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1151-1210, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32152-9. Acesso em: 06 out. 2024.
APA
Goulart, A. C., Santos, I. de S., Benseñor, I. M., Lotufo, P. A., Furtado, J. M. F., & Wang, Y. -P. (2017). Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1151-1210. doi:10.1016/S0140-6736(17)32152-9
NLM
Goulart AC, Santos I de S, Benseñor IM, Lotufo PA, Furtado JMF, Wang Y-P. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1151-1210.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32152-9
Vancouver
Goulart AC, Santos I de S, Benseñor IM, Lotufo PA, Furtado JMF, Wang Y-P. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1151-1210.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32152-9
Artigo de periodico
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Source: Lancet. Unidades: FM, HU, FMRP
Subjects: EXPRESSÃO AMBIENTAL, POLÍTICAS PÚBLICAS, FATORES DE RISCO, DESENVOLVIMENTO SUSTENTÁVEL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1345-1422, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32366-8. Acesso em: 06 out. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1345-1422. doi:10.1016/S0140-6736(17)32366-8
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1345-1422.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32366-8
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1345-1422.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)32366-8
Artigo de periodico
Newborn health research priorities beyond 2015 (2014)
Yoshida, Sachiyo; Rudan, Igor; Lawn, Joy E; Wall, Stephen; Souza, João Paulo Dias de; Martines, José; Bahl, Rajiv
Source: Lancet. Unidade: FMRP
Subjects: PARTO, PRIORIDADES EM SAÚDE (TENDÊNCIAS), CUIDADO DO LACTENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOSHIDA, Sachiyo et al. Newborn health research priorities beyond 2015. Lancet, v. 384, n. 9938, p. e27-e29, 2014Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(14)60263-4. Acesso em: 06 out. 2024.
APA
Yoshida, S., Rudan, I., Lawn, J. E., Wall, S., Souza, J. P. D. de, Martines, J., & Bahl, R. (2014). Newborn health research priorities beyond 2015. Lancet, 384( 9938), e27-e29. doi:10.1016/S0140-6736(14)60263-4
NLM
Yoshida S, Rudan I, Lawn JE, Wall S, Souza JPD de, Martines J, Bahl R. Newborn health research priorities beyond 2015 [Internet]. Lancet. 2014 ; 384( 9938): e27-e29.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(14)60263-4
Vancouver
Yoshida S, Rudan I, Lawn JE, Wall S, Souza JPD de, Martines J, Bahl R. Newborn health research priorities beyond 2015 [Internet]. Lancet. 2014 ; 384( 9938): e27-e29.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(14)60263-4
Artigo de periodico
Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health (2014)
Vogel, Joshua P; Souza, João Paulo Dias de; Gülmezoglu, A Metin; Mori, Rintaro; Lumbiganon, Pisake; Qureshi, Zahida; Carroli, Guillermo; Laopaiboon, Malinee; Fawole, Bukola; Ganchimeg, Togoobaatar; Zhang, Jun; Torloni, Maria Regina; Bohren, Meghan; Temmerman, Marleen
Source: Lancet. Unidade: FMRP
Subjects: HORMÔNIOS DO CÓRTEX ADRENAL (ADMINISTRAÇÃO E DOSAGEM), GRAVIDEZ, NASCIMENTO PREMATURO (PREVENÇÃO E CONTROLE), CUIDADO PRÉ-NATAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VOGEL, Joshua P et al. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Lancet, v. 384, n. 9957, p. 1869-1877, 2014Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(14)60580-8. Acesso em: 06 out. 2024.
APA
Vogel, J. P., Souza, J. P. D. de, Gülmezoglu, A. M., Mori, R., Lumbiganon, P., Qureshi, Z., et al. (2014). Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Lancet, 384( 9957), 1869-1877. doi:10.1016/S0140-6736(14)60580-8
NLM
Vogel JP, Souza JPD de, Gülmezoglu AM, Mori R, Lumbiganon P, Qureshi Z, Carroli G, Laopaiboon M, Fawole B, Ganchimeg T, Zhang J, Torloni MR, Bohren M, Temmerman M. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health [Internet]. Lancet. 2014 ; 384( 9957): 1869-1877.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(14)60580-8
Vancouver
Vogel JP, Souza JPD de, Gülmezoglu AM, Mori R, Lumbiganon P, Qureshi Z, Carroli G, Laopaiboon M, Fawole B, Ganchimeg T, Zhang J, Torloni MR, Bohren M, Temmerman M. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health [Internet]. Lancet. 2014 ; 384( 9957): 1869-1877.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/S0140-6736(14)60580-8
Artigo de periodico-carta/editorial
Oral sucrose for procedural pain in infants [Carta] (2011)
Linhares, Maria Beatriz Martins; Gaspardo, Cláudia Maria; Martinez, Francisco Eulogio
Source: Lancet. Unidade: FMRP
Subjects: LACTENTES, DOR, SACAROSE (EFEITOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LINHARES, Maria Beatriz Martins e GASPARDO, Cláudia Maria e MARTINEZ, Francisco Eulogio. Oral sucrose for procedural pain in infants [Carta]. Lancet. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 06 out. 2024. , 2011
APA
Linhares, M. B. M., Gaspardo, C. M., & Martinez, F. E. (2011). Oral sucrose for procedural pain in infants [Carta]. Lancet. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Linhares MBM, Gaspardo CM, Martinez FE. Oral sucrose for procedural pain in infants [Carta]. Lancet. 2011 ; 377( 9759): 25-27.[citado 2024 out. 06 ]
Vancouver
Linhares MBM, Gaspardo CM, Martinez FE. Oral sucrose for procedural pain in infants [Carta]. Lancet. 2011 ; 377( 9759): 25-27.[citado 2024 out. 06 ]
Artigo de periodico
Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial (2008)
Marin-Neto, José Antônio
Source: Lancet. Unidade: FMRP
Assunto: CARDIOLOGIA (CIRURGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet, v. 371, n. 9627, p. 1839-1847, 2008Tradução . . Acesso em: 06 out. 2024.
APA
Marin-Neto, J. A. (2008). Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet, 371( 9627), 1839-1847.
NLM
Marin-Neto JA. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 ; 371( 9627): 1839-1847.[citado 2024 out. 06 ]
Vancouver
Marin-Neto JA. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 ; 371( 9627): 1839-1847.[citado 2024 out. 06 ]
Artigo de periodico
Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial (2008)
Marin-Neto, José Antônio
Source: Lancet. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, ANGIOTENSINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet, v. 372, n. 9644, p. 1174-1183, 2008Tradução . . Acesso em: 06 out. 2024.
APA
Marin-Neto, J. A. (2008). Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet, 372( 9644), 1174-1183.
NLM
Marin-Neto JA. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 ; 372( 9644): 1174-1183.[citado 2024 out. 06 ]
Vancouver
Marin-Neto JA. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 ; 372( 9644): 1174-1183.[citado 2024 out. 06 ]
Artigo de periodico
Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled (2008)
Marin-Neto, José Antônio
Source: Lancet. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA RENAL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, v. 372, n. 9638, p. 547-553, 2008Tradução . . Acesso em: 06 out. 2024.
APA
Marin-Neto, J. A. (2008). Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, 372( 9638), 547-553.
NLM
Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 out. 06 ]
Vancouver
Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 out. 06 ]
Artigo de periodico
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial (2006)
Marin Neto, J A
Source: Lancet. Unidade: FMRP
Assunto: DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN NETO, J A. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet, v. 367, n. 9526, p. 1903-1912, 2006Tradução . . Acesso em: 06 out. 2024.
APA
Marin Neto, J. A. (2006). Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet, 367( 9526), 1903-1912.
NLM
Marin Neto JA. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006 ; 367( 9526): 1903-1912.[citado 2024 out. 06 ]
Vancouver
Marin Neto JA. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006 ; 367( 9526): 1903-1912.[citado 2024 out. 06 ]
Artigo de periodico
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction (2001)
Marin-Neto, José Antônio
Source: Lancet. Unidade: FMRP
Subjects: INFARTO DO MIOCÁRDIO (TRATAMENTO), ISQUEMIA MIOCÁRDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet, v. 358, n. 9282, p. 605-613, 2001Tradução . . Acesso em: 06 out. 2024.
APA
Marin-Neto, J. A. (2001). Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet, 358( 9282), 605-613.
NLM
Marin-Neto JA. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001 ; 358( 9282): 605-613.[citado 2024 out. 06 ]
Vancouver
Marin-Neto JA. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001 ; 358( 9282): 605-613.[citado 2024 out. 06 ]
Artigo de periodico
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study (2001)
Mehta, Shamir R.; Yusuf, Salim; Peters, Ron J. G.; Bertrand, Michel E.; Lewis, Basil S.; Natarajan, Madhu K.; Malmberg, Klas; Rupprecht, Hans-Jürgen; Zhao, Feng; Chrolavicius, Suzan; Copland, Ingrid; Fox, K. A. A.; Marin-Neto, José Antônio
Source: Lancet. Unidade: FMRP
Subjects: FÁRMACOS SINTÉTICOS, MEDICAÇÃO ORAL, ISQUEMIA MIOCÁRDICA (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Shamir R. et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, v. 358, n. 9281, p. 527-533, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(01)05701-4. Acesso em: 06 out. 2024.
APA
Mehta, S. R., Yusuf, S., Peters, R. J. G., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., et al. (2001). Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 358( 9281), 527-533. doi:10.1016/s0140-6736(01)05701-4
NLM
Mehta SR, Yusuf S, Peters RJG, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H-J, Zhao F, Chrolavicius S, Copland I, Fox KAA, Marin-Neto JA. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [Internet]. Lancet. 2001 ; 358( 9281): 527-533.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/s0140-6736(01)05701-4
Vancouver
Mehta SR, Yusuf S, Peters RJG, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H-J, Zhao F, Chrolavicius S, Copland I, Fox KAA, Marin-Neto JA. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [Internet]. Lancet. 2001 ; 358( 9281): 527-533.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/s0140-6736(01)05701-4
Artigo de periodico
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial (1999)
Werf, Frans Van de; Marin Neto, José Antonio
Source: Lancet. Unidade: FMRP
Subjects: CARDIOPATIAS, MEDICINA INTERNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WERF, Frans Van de e MARIN NETO, José Antonio. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet, v. 354, p. 716-722, 1999Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(99)07403-6. Acesso em: 06 out. 2024.
APA
Werf, F. V. de, & Marin Neto, J. A. (1999). Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet, 354, 716-722. doi:10.1016/s0140-6736(99)07403-6
NLM
Werf FV de, Marin Neto JA. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial [Internet]. Lancet. 1999 ; 354 716-722.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/s0140-6736(99)07403-6
Vancouver
Werf FV de, Marin Neto JA. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial [Internet]. Lancet. 1999 ; 354 716-722.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/s0140-6736(99)07403-6

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration